Fig. 3
From: A three-gene expression-based risk score can refine the European LeukemiaNet AML classification
TriAS refines the ELN classification to better segregate AML survival. Overall survival of the AML patients from the TCGA and NUTH data sets according to current ELN classification is shown (a) or after implementation of the ELN and TriAS classification (ELN + TriAS) (c). The fraction of patients reclassified based on original ELN and ELN + TriAS risk classification is shown (b)